Replies to post #1128 on Dyadic International Inc (DYAI)

[blue_skies]

looks like it is taking the express train to a dollar?!

[blue_skies]

Dyadic's DYAI-100 COVID-19 Vaccine Study Published in a Leading Peer-Reviewed Scientific Journal
https://finance.yahoo.com/news/dyadics-dyai-100-covid-19-133000691.html

In summary, glycoprotein vaccine manufacturing C1 production platform appears
entirely suitable for rapid commercial development of SARS-CoV-2 vaccine, which would
be relatively unaffected by lack of resources, such as shortages of materials (e.g., plastic
bags for insect cell vaccine manufacturing), equipment, expensive media, and cold-chain
freezers. Based on the data of this study and further development under GMP conditions
for the first time, a subunit antigen vaccine produced in C1-cells received regulatory approval to initiate a Phase 1 clinical trial to demonstrate safety and efficacy in humans [55].

The above quote is taken from the published paper.

[blue_skies]

I think when people give up on a stock is the time to start buying.
HC Wainwright & Co. Reiterates Buy on Dyadic International, Maintains $6 Price Target
i do not believe the $6 price target but I feel the risk reward is favorable and the story is good.